BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
38 hedge funds and large institutions have $5.58M invested in Baudax Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 13 closing their positions.
Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
8
Reduced
5
Closed
13
Calls
$361K
Puts
$17K
Net Calls
+$344K
Net Calls Change
-$450K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$276K |
2 |
2
State Street
Boston,
Massachusetts
|
$216K |
3 |
3
Goldman Sachs
New York
|
$115K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$406K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$135K |